Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
How to Pay for Health Care
Porter, Michael E.; Kaplan, Robert S.Artículo HBS-R1607G-ELiderazgo y Dirección de personasThe United States stands at a crossroads in how to pay for health care. Fee for service, the dominant payment model in the U.S. and many other countries, is now widely recognized as perhaps the single biggest obstacle to improving health care delivery. A battle is currently raging, outside of the public eye, between the advocates of two radically different payment approaches: capitation and bundled payments. The stakes are high, and the outcome w...Desde 8,20 €
-
How to Solve the Cost Crisis in Health Care
Kaplan, Robert S.; Porter, Michael E.Artículo HBS-R1109B-ELiderazgo y Dirección de personasU.S. health care costs currently exceed 17% of GDP and continue to rise. One fundamental reason that providers are unable to reverse the trend is that they don't understand what it costs to deliver patient care or how those costs compare with outcomes. To put it bluntly, few health care providers measure the actual costs for treating a given patient with a given medical condition over a full cycle of care, or compare the costs they incur with the...Desde 8,20 €
-
George's T-Shirts
Frey, Sherwood C. Jr.; Pfeifer, Phillip E.Caso DARDEN-QA-0346-EAnálisis de decisionesGeorge Lasiter sells special-events T-shirts and must decide how many to order for an upcoming concert. He has high, medium, and low estimates of both concert attendance and the percentage of attendees who will want a shirt. In addition, he has assessed the relative likelihoods of each estimate. The case can be used to introduce or reinforce the fundamental issues surrounding decision making under uncertainty.Desde 8,20 €
-
Merck & Company: Product KL-798
Frey, Sherwood C. Jr.; Bodily, Samuel E.Caso DARDEN-QA-0582-EAnálisis de decisionesMerck has been approached by a small biotech research firm with the proposal that Merck buy the rights to a new drug that promises to treat obesity and lower cholesterol. The drug is in the middle of phase I of the FDA approval process. Pat Harlow, the chief licensing officer, has been leading Merck's investigation team. A meeting is scheduled for tomorrow at which Merck's response to the offer will be drafted.Desde 8,20 €
-
How to Solve the Cost Crisis in Health Care (Spanish version)
Kaplan, Robert S.; Porter, Michael E.Artículo HBS-R1109BLiderazgo y Dirección de personasU.S. health care costs currently exceed 17% of GDP and continue to rise. One fundamental reason that providers are unable to reverse the trend is that they don't understand what it costs to deliver patient care or how those costs compare with outcomes. To put it bluntly, few health care providers measure the actual costs for treating a given patient with a given medical condition over a full cycle of care, or compare the costs they incur with the...Desde 8,20 €
-
Merck & Company: Product KL-798 (Spanish version)
Frey, Sherwood C. Jr.; Bodily, Samuel E.Caso DARDEN-QA-0910Análisis de decisionesEsta es una traducción al español de la versión del 14 de junio de 2016 del caso UVA-QA-0582. Merck ha sido contactado por una pequeña empresa de investigación en biotecnología con una propuesta para que Merck compre los derechos de un nuevo medicamento que promete tratar la obesidad y reducir el colesterol. El medicamento se encuentra en la mitad de la fase I del proceso de aprobación de la FDA. Pat Harlow, el director de licencias, ha estado al...Desde 8,20 €
-
Medtronic: Navigating a Shifting Healthcare Landscape
Kaplan, Robert S.; Porter, Michael E.; Feeley, Thomas W; Hernandez, AleeCaso HBS-718471-EDirección estratégicaMedtronic is adapting its strategy to changes in health care competition and payments. It has decided to develop new relationships with payers, hospitals, and physicians to become more accountable for patient outcomes and total costs. The case describes new forms of partnerships for therapy optimization, management of acute care episodes, and management of chronic care patients.Desde 8,20 €
-
New England Baptist Hospital: Getting Paid for Value
Kaplan, Robert S.; Witkowski, Mary L.; Emanuel, Toby E.; Shehab, Syed S.Caso HBS-121036-EDirección estratégicaDesde 8,20 €
-
Accounting for Climate Change
Kaplan, Robert S.; Ramanna, KarthikArtículo HBS-R2106J-EDirección estratégicaCorporations are facing growing pressure--from investors, advocacy groups, politicians, and even business leaders themselves--to reduce greenhouse gas (GHG) emissions from their operations and their supply and distribution chains. About 90% of the companies in the S&P 500 now issue some form of environmental, social, and governance report, almost always including an estimate of the company's GHG emissions. The authors describe these as "catchall ...Desde 8,20 €
-
Madison House: Riley Carter
Frey, Sherwood C. Jr.; Bass, Lucien; Grant, MaxCaso DARDEN-QA-0803-EAnálisis de decisionesThis two-part negotiation exercise is used in Negotiations electives at both the Darden School of Business and the McIntire School of Commerce. Together the cases provide the background for a scorable, bilateral, multi-issue negotiation in which there are congruent, distributive, and integrative issues. People and Congregations Engaged in Ministry (PACEM) was a nonprofit organization committed to helping homeless adults in the Charlottesville, Vi...Desde 8,20 €